KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,762,729 | -64.4% | 126,815 | -41.1% | 0.01% | -60.9% |
| Q2 2023 | $4,947,609 | -33.6% | 215,207 | -14.4% | 0.02% | -37.8% |
| Q1 2023 | $7,447,826 | +113.3% | 251,361 | +79.7% | 0.04% | +94.7% |
| Q4 2022 | $3,491,604 | -12.7% | 139,888 | -23.9% | 0.02% | -13.6% |
| Q3 2022 | $4,000,000 | +17.9% | 183,719 | +6.6% | 0.02% | +22.2% |
| Q2 2022 | $3,392,000 | +44.3% | 172,272 | +255.5% | 0.02% | +12.5% |
| Q2 2021 | $2,350,000 | -39.1% | 48,460 | -51.2% | 0.02% | -42.9% |
| Q1 2021 | $3,861,000 | – | 99,365 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |